Most notably, both IGF2 and the maternally expressed cell cycle inhibitor CDKN1C can contribute to the overgrowth disorders seen in Beckwith-Wiedemann syndrome [36] and there is evidence that changes in Igf2 expression can influence expression of Cdkn1c [37]. This evidence concerns the gene IGF2 and Beckwith-Wiedemann syndrome.